FindTrial
Sign In

Clinical study for Hirudoid in the treatment of rose acne

Clinical study for Hirudoid in the treatment of rose acne

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900020985
Enrollment
Unknown
Registered
2019-01-23
Start date
2019-03-01
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rose acne

Interventions

Case series:Apply Hirudoid on the left side of the face

Sponsors

Dermatology Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with mild to moderate rose acne; 2. Aged at least 18 years old; 3. Can understand the entire content of this test and complete it as required; 4. Have not used anti-inflammatory drugs in the past month; 5. Sign the volunteer informed consent form.

Exclusion criteria

Exclusion criteria: 1. Adverse reactions to hi treatment; 2. Have systemic or skin infectious diseases; 3. Long-term use of anti-inflammatory preparations or drugs.

Design outcomes

Primary

MeasureTime frame
Stratum corneum;transepidermal water loss;PH;VISA;Antera;SCORECARD;—

Countries

China

Contacts

Public ContactMan Maoqiang

Dermatology Hospital of Southern Medical University

mqman@hotmail.com+86 18213959811

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026